| # | Title | Journal | Year | Citations |
|---|
| 1 | Biological subtypes of breast cancer: Prognostic and therapeutic implications | World Journal of Clinical Oncology | 2014 | 688 |
| 2 | High intensity focused ultrasound in clinical tumor ablation | World Journal of Clinical Oncology | 2011 | 450 |
| 3 | Challenges to the early diagnosis and treatment of breast cancer in developing countries | World Journal of Clinical Oncology | 2014 | 260 |
| 4 | Historical review of the causes of cancer | World Journal of Clinical Oncology | 2016 | 227 |
| 5 | Targeted therapies in breast cancer: New challenges to fight against resistance | World Journal of Clinical Oncology | 2017 | 227 |
| 6 | Therapeutic management options for stage III non-small cell lung cancer | World Journal of Clinical Oncology | 2017 | 188 |
| 7 | Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices | World Journal of Clinical Oncology | 2015 | 185 |
| 8 | Tyrosine kinase inhibitors: Multi-targeted or single-targeted? | World Journal of Clinical Oncology | 2011 | 184 |
| 9 | Pathogenesis, prevention, diagnosis and treatment of breast cancer | World Journal of Clinical Oncology | 2014 | 184 |
| 10 | Significance of immunohistochemistry in breast cancer | World Journal of Clinical Oncology | 2014 | 172 |
| 11 | Paraneoplastic syndromes associated with lung cancer Nobuhiro Kanaji, Naoki Watanabe, Nobuyuki Kita, Shuji Bandoh, Akira Tadokoro, Tomoya Ishii, Hiroaki Dobashi, Takuya Matsunaga | World Journal of Clinical Oncology | 2014 | 166 |
| 12 | Cyclooxygenase-2 and the inflammogenesis of breast cancer | World Journal of Clinical Oncology | 2014 | 143 |
| 13 | Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management | World Journal of Clinical Oncology | 2014 | 136 |
| 14 | Magnetic resonance imaging in breast cancer: A literature review and future perspectives | World Journal of Clinical Oncology | 2014 | 133 |
| 15 | Overview, prevention and management of chemotherapy extravasation | World Journal of Clinical Oncology | 2016 | 132 |
| 16 | Breast imaging: A survey | World Journal of Clinical Oncology | 2011 | 122 |
| 17 | Twenty-five years of research on the effects of exercise training in breast cancer survivors: A systematic review of the literature | World Journal of Clinical Oncology | 2014 | 120 |
| 18 | Weight gain following breast cancer diagnosis: Implication and proposed mechanisms | World Journal of Clinical Oncology | 2014 | 113 |
| 19 | Platinum-induced neurotoxicity: A review of possible mechanisms | World Journal of Clinical Oncology | 2017 | 112 |
| 20 | Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia | World Journal of Clinical Oncology | 2014 | 105 |
| 21 | Long non-coding RNAs in stem cells and cancer | World Journal of Clinical Oncology | 2014 | 104 |
| 22 | A complete compilation of matrix metalloproteinase expression in human malignant gliomas | World Journal of Clinical Oncology | 2012 | 101 |
| 23 | Role of copper transporters in platinum resistance | World Journal of Clinical Oncology | 2016 | 99 |
| 24 | Colorectal liver metastases: Current management and future perspectives | World Journal of Clinical Oncology | 2020 | 98 |
| 25 | Biomarkers in triple negative breast cancer: A review | World Journal of Clinical Oncology | 2015 | 97 |
| 26 | Update on prevention and screening of cervical cancer | World Journal of Clinical Oncology | 2014 | 93 |
| 27 | IL-6/IL-6R as a potential key signaling pathway in prostate cancer development | World Journal of Clinical Oncology | 2011 | 93 |
| 28 | Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal | World Journal of Clinical Oncology | 2014 | 90 |
| 29 | Systemic treatment strategies for triple-negative breast cancer | World Journal of Clinical Oncology | 2014 | 90 |
| 30 | Glucan-immunostimulant, adjuvant, potential drug | World Journal of Clinical Oncology | 2011 | 88 |
| 31 | Oncogenic driver mutations in non-small cell lung cancer: Past, present and future | World Journal of Clinical Oncology | 2021 | 88 |
| 32 | Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions | World Journal of Clinical Oncology | 2014 | 87 |
| 33 | Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options | World Journal of Clinical Oncology | 2011 | 86 |
| 34 | Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention | World Journal of Clinical Oncology | 2015 | 83 |
| 35 | MicroRNAs as lung cancer biomarkers | World Journal of Clinical Oncology | 2014 | 82 |
| 36 | Breast cancer in India: Present scenario and the challenges ahead | World Journal of Clinical Oncology | 2022 | 82 |
| 37 | Inhibition of carbonic anhydrase IX as a novel anticancer mechanism | World Journal of Clinical Oncology | 2012 | 79 |
| 38 | Imaging of gastroenteropancreatic neuroendocrine tumors | World Journal of Clinical Oncology | 2011 | 76 |
| 39 | FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case series | World Journal of Clinical Oncology | 2011 | 75 |
| 40 | Green tea compounds in breast cancer prevention and treatment | World Journal of Clinical Oncology | 2014 | 74 |
| 41 | Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma | World Journal of Clinical Oncology | 2017 | 73 |
| 42 | Endoscopic diagnosis of extrahepatic bile duct carcinoma: Advances and current limitations | World Journal of Clinical Oncology | 2011 | 72 |
| 43 | Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians | World Journal of Clinical Oncology | 2016 | 71 |
| 44 | DNA damage and breast cancer | World Journal of Clinical Oncology | 2011 | 69 |
| 45 | Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data | World Journal of Clinical Oncology | 2018 | 69 |
| 46 | Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide | World Journal of Clinical Oncology | 2019 | 67 |
| 47 | Chronic obstructive pulmonary disease as a risk factor for lung cancer | World Journal of Clinical Oncology | 2014 | 65 |
| 48 | Phytoestrogens and prevention of breast cancer: The contentious debate | World Journal of Clinical Oncology | 2014 | 64 |
| 49 | From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis | World Journal of Clinical Oncology | 2017 | 64 |
| 50 | Nephrotoxicity in cancer treatment: An overview | World Journal of Clinical Oncology | 2020 | 64 |
